Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Nestle sales & earnings

This article was originally published in The Tan Sheet

Executive Summary

Nestle's Nutrition sales grew 6.1% to 6 bil. Swiss Francs ($4.68 bil.) helped by an improvement in China, while total sales for 2006 were 98.5 bil. Swiss Francs ($79.8 bil.) up 8.1%. The Switzerland-based firm achieved strong gains in infant nutrition as a result of the international roll-out of infant formula product Nestle NAN HA, according to a sales and earnings report. "We are seeing the benefits of the group's transformation into a nutrition, health and wellness company, with stronger innovation and branding, as well as improved efficiency," Nestle Chairman and CEO Peter Brabeck-Letmathe says. Products enriched with Branded Active Benefits achieved organic growth of more than 20% in 2006 with sales close to 4 bil. Swiss Francs ($3.24 bil.), the company says. Nestle says beverages achieved 8% organic growth to 25.9 bil. Swiss Francs ($21 bil.)...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS100254

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel